Abstract
Antagonism between fosfomycin and antipseudomonal penicillins, cefotaxime, and ceftriaxone was observed in Pseudomonas aeruginosa RYC212. Fosfomycin, a non-beta-lactam antibiotic that acts on bacterial cell wall synthesis, decreased the expression of penicillin-binding protein 3 and induced beta-lactamase. The antagonistic effect was reduced in the presence of high concentrations of the beta-lactamase inhibitor tazobactam or in fosfomycin-resistant mutants. We suggest that products resulting from fosfomycin cell wall damage could interact with a system that regulates penicillin-binding protein and beta-lactamase production.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Bacterial Outer Membrane Proteins / metabolism
-
Bacterial Proteins*
-
Carrier Proteins*
-
Cefotaxime / pharmacology
-
Ceftriaxone / pharmacology
-
Fosfomycin / antagonists & inhibitors*
-
Hexosyltransferases / biosynthesis
-
Hexosyltransferases / metabolism*
-
Microbial Sensitivity Tests
-
Multienzyme Complexes / biosynthesis
-
Multienzyme Complexes / metabolism*
-
Muramoylpentapeptide Carboxypeptidase*
-
Penicillin-Binding Proteins
-
Penicillins / pharmacology
-
Peptidyl Transferases / biosynthesis
-
Peptidyl Transferases / metabolism*
-
Pseudomonas aeruginosa / drug effects
-
Pseudomonas aeruginosa / enzymology
-
Pseudomonas aeruginosa / metabolism*
-
beta-Lactamases / biosynthesis
Substances
-
Anti-Bacterial Agents
-
Bacterial Outer Membrane Proteins
-
Bacterial Proteins
-
Carrier Proteins
-
Multienzyme Complexes
-
Penicillin-Binding Proteins
-
Penicillins
-
Fosfomycin
-
Ceftriaxone
-
Peptidyl Transferases
-
Hexosyltransferases
-
Muramoylpentapeptide Carboxypeptidase
-
beta-Lactamases
-
Cefotaxime